General Information of the Compound
Compound ID |
CP0447158
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide
Show/Hide
|
||||||||||||||||||
Synonyms |
2-(4-chlorophenyl)-3-methyl-N-(1,3-thiazol-2-yl)butanamide
2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide
300851-67-6
4-CMTB
4-CMTB, >
4-chloro- -(1-methylethyl)-N-2-thiazolylbenzeneacetamide
AC1N7SQ9
AC1Q1O0T
AKOS001033996
AKOS016375538
AOB5572
BDBM50305973
CHEBI:113043
CHEMBL610463
Enamine_000061
GTPL5500
HMS1394C17
HMS2644I21
MCULE-6415878091
MLS001018069
MolPort-000-514-794
Oprea1_875848
SCHEMBL16369644
SMR000354300
SR-01000025543
SR-01000025543-1
Z28173527
cid_4307629
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H15ClN2OS
|
||||||||||||||||||
Molecular Weight |
294.807
|
||||||||||||||||||
Canonical SMILES |
CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H15ClN2OS/c1-9(2)12(10-3-5-11(15)6-4-10)13(18)17-14-16-7-8-19-14/h3-9,12H,1-2H3,(H,16,17,18)
Show/Hide
|
||||||||||||||||||
InChIKey |
AZYDQCGCBQYFSE-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04096, Free fatty acid receptor 2
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Clinical Information about the Compound
Drug 1 ( 4-CMTB )
Drug Name | 4-CMTB |
---|